Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Large study looks at how a 25-Gene cancer test affects patients and families

NCT ID NCT02324062

First seen Feb 23, 2026 · Last updated Jun 23, 2026 · Updated 19 times

Summary

This study looked at how a genetic test that checks 25 genes linked to hereditary cancers is used in clinics. Over 1,500 people with a personal or family history of cancer took part. Researchers collected blood samples and had participants fill out questionnaires over five years to learn about their experiences and how the test results affected their care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEUTZ-JEGHERS SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Stanford University

    Stanford, California, 94305, United States

  • University of Southern California/ Kenneth Norris, Jr. Comprehensive Cancer Center and Hospital

    Los Angeles, California, 90089-9181, United States

Conditions

The condition(s) this trial relates to.

ataxia telangiectasia attenuated familial adenomatous polyposis classic familial adenomatous polyposis Cowden disease familial melanoma hereditary breast ovarian cancer syndrome hereditary diffuse gastric adenocarcinoma hereditary neoplastic syndrome juvenile polyposis syndrome Li-Fraumeni syndrome Lynch syndrome Peutz-Jeghers syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.